Table 1 Summary of data arising from experiments utilizing 'omics' technologies.
Study (Compartment) | I (Plasma) | II (Plasma) | III (Plasma) | IV (Plasma) | V (Tissue) | VIa (Tissue) | VIb (Plasma) | VIIa (Tissue) | VIIb (Plasma) |
|---|---|---|---|---|---|---|---|---|---|
Disease area | Organ Toxicity | Cardio-vascular Disease | Infectious Disease | Neuro-muscular Disease | Organ Toxicity | Organ Toxicity | Organ Toxicity | ||
Species | Human | Human | Mouse | Mouse | Rat | Rat | Rat | ||
Platforms | |||||||||
- GC/MS | √ | √ | √ |  |  |  | √ |  |  |
- Lipid LC/MS | √ | √ | √ | √ | √ | √ | √ | √ | √ |
- Polar LC/MS | √ | √ | √ | √ | √ | √ | √ | √ | √ |
- Proteomics (Mass Spectrometry) | √ | √ | √ | √ | √ |  |  | √ | √ |
- Proteomics (Multiplexed Immunoassay) |  | √ |  |  |  |  |  |  | √ |